Shi, Chengzhang <br/><br/>
BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma.  [electronic resource] 

 -  Neuro-oncology  08 2020 
 - 1114-1125 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-5866 
<br/><br/><label>Standard No.: </label>10.1093/neuonc/noaa084  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoma--drug therapy<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Cycle Proteins--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Growth Hormone-Secreting Pituitary Adenoma--drug therapy<br/>Humans<br/>Mice<br/>Molecular Targeted Therapy<br/>Pituitary Neoplasms--drug therapy<br/>Rats<br/>Transcription Factors--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays